載入...
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment
Long-term survivors of Hodgkin lymphoma (HL) experience several late adverse effects of treatment, with second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs) being the leading causes of death in these patients. Other late effects have also been identified, such as pulmonary dysfunctio...
Na minha lista:
| 發表在: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142518/ https://ncbi.nlm.nih.gov/pubmed/27913498 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|